Zero Mortality During Covid-19 Outbreak: A Review in 418 Workers at a Health University

Main Article Content

Sudiro Sudiro
Satino Satino
Yuyun Setyorini
Yopi Harwinandha Ardesa
Rendi Editya Darmawan


Background: Mortality due to Covid-19 outbreak in Indonesia are the second highest in Asia on period 2020-2021, but there is one of health university that zero mortality. Some of the factors that cause high mortality are only assumptions from researchers, need to be clarified scientifically. Aim of study is to analyze factors that causes zero mortality during covid-19 outbreak.

 Methods: We performed a descriptive study using result of medical check up workers within the first 1 year of the pandemic. All workers consist of lecturers, administrative staff, drivers, and cleaning staff were included as much as 418 persons. Patients were assessed for their gender, age, body mass index, blood pressure, total cholesterol, and electrocardiography based on laboratory test and interview. We analyze data using descriptive based on characteristics respondents. Data collected in December 2021. The examination is carried out by a certified laboratory.

 Results: The age of the workers is mostly young, the small incidence of hypertension, hypercholesterolemia, and heart health problems, have the potential to be a reason for zero mortality during the covid 19 outbreak in 418 workers. Hypertension, gender, obesity, hypercholesterolemia, and aritmia unrelated to mortality, but related to severity.  Age directly related to mortality.

 Conclusion: A healthy body is an asset in dealing with a pandemic. Periodic checks on blood sugar, electrocardiography, cholesterol, body mass index, is needed in preparing for the next pandemic minimum once every 6 months.

Article Details

How to Cite
Sudiro, S., Satino, S., Setyorini, Y., Ardesa, Y. H. ., & Darmawan, R. E. (2023). Zero Mortality During Covid-19 Outbreak: A Review in 418 Workers at a Health University. (JKG) Jurnal Keperawatan Global, 8(1), 13–21.


Abumweis, S., Alrefai, W., & Alzoughool, F. (2022). Association of obesity with COVID-19 diseases severity and mortality: A meta-analysis of studies. Obesity Medicine, 33(May), 100431.

Alissa, D. A., Aburas, W., Almasuood, R., Almudaiheem, H. Y., Al Aseri, Z., Alrabiah, F., … Al-jedai, A. H. (2023). Prevalence and epidemiological trends in mortality due to COVID-19 in Saudi Arabia. Public Health, 215, 31–38.

An, J., Zhou, H., Luong, T. Q., Wei, R., Mefford, M. T., Harrison, T. N., … Reynolds, K. (2021). Risk of hospitalization and mortality associated with uncontrolled blood pressure in patients with hypertension and COVID-19. International Journal of Cardiology: Cardiovascular Risk and Prevention, 11.

Bölen, F., Baycan, O. F., Cesur, A., & Agirbasli, M. A. (2022). Uric Acid To High Density Lipoprotein Cholesterol Ratio Is a Significant Predictor of Mortality in Patients Hospitalized With Covid-19. Journal of the American College of Cardiology, 79(9), 2076.

Chang, Y., Jeon, J., Song, T. J., & Kim, J. (2023). Association of triglyceride/high-density lipoprotein cholesterol ratio with severe complications of COVID-19. Heliyon, 9(6).

Cunha, M. C. A., Schardong, J., Righi, N. C., Lunardi, A. C., Sant’Anna, G. N., Isensee, L. P., … Carvalho, C. R. F. (2023). Aging-related predictive factors for oxygenation improvement and mortality in COVID-19 and acute respiratory distress syndrome (ARDS) patients exposed to prone position: A multicenter cohort study. Clinics, 78(September 2022), 100180.

Du, Y., Zhou, N., Zha, W., & Lv, Y. (2021). Hypertension is a clinically important risk factor for critical illness and mortality in COVID-19: A meta-analysis. Nutrition, Metabolism and Cardiovascular Diseases, 31(3), 745–755.

Dyusupova, A., Faizova, R., Yurkovskaya, O., Belyaeva, T., Terekhova, T., Khismetova, A., … Glushkova, N. (2021). Clinical characteristics and risk factors for disease severity and mortality of COVID-19 patients with diabetes mellitus in Kazakhstan: A nationwide study. Heliyon, 7(3), e06561.

Eryilmaz-Eren, E., Ture, Z., Kilinç-Toker, A., Korkmaz, S., & Çelik, İ. (2022). The course of COVID-19 in patients with hematological malignancies and risk factors affecting mortality: A cross-sectional study. Hematology, Transfusion and Cell Therapy, (xx), 1–5.

Feng, Z. (2023). Spatiotemporal pattern of COVID-19 mortality and its relationship with socioeconomic and environmental factors in England. Spatial and Spatio-Temporal Epidemiology, 45(May 2022), 100579.

Harbuwono, D. S., Handayani, D. O. T. L., Wahyuningsih, E. S., Supraptowati, N., Ananda, Kurniawan, F., … Tahapary, D. L. (2022). Impact of diabetes mellitus on COVID-19 clinical symptoms and mortality: Jakarta’s COVID-19 epidemiological registry. Primary Care Diabetes, 16(1), 65–68.

Hernández-Vásquez, A., Visconti-Lopez, F. J., Alburqueque-Cruz, R., & Rojas-Roque, C. (2023). Hospitalizations and mortality of patients with heart failure in the COVID-19 era in Peru. Journal of Taibah University Medical Sciences, 18(1), 186–189.

Heymann, D. L. (2020). A novel coronavirus outbreak of global health concern. Thelancet, 395, 15–18.

Hwang, T. J., Rabheru, K., Peisah, C., Reichman, W., & Ikeda, M. (2020). Loneliness and social isolation during the COVID-19 pandemic. International Psychogeriatrics, 32(10), 1217–1220.

Lu, J. Y., Wilson, J., Hou, W., Fleysher, R., Herold, B. C., Herold, K. C., & Duong, T. Q. (2023). Incidence of new-onset in-hospital and persistent diabetes in COVID-19 patients: comparison with influenza. EBioMedicine, 90, 104487.

Lv, F., Gao, X., Huang, A. H., Zu, J., He, X., Sun, X., … Ji, F. (2022). Excess diabetes mellitus-related deaths during the COVID-19 pandemic in the United States. EClinicalMedicine, 54(September), 101671.

Martín-del-Campo, F., Ruvalcaba-Contreras, N., Velázquez-Vidaurri, A. L., Cueto-Manzano, A. M., Rojas-Campos, E., Cortés-Sanabria, L., … Mireles-Ramírez, M. (2021). Morbid obesity is associated with mortality and acute kidney injury in hospitalized patients with COVID-19. Clinical Nutrition ESPEN, 45, 200–205.

Nadakinamani, R. G., Reyana, A., Gupta, Y., Kautish, S., Ghorashi, S., Jamjoom, M. M., & Wagdy Mohamed, A. (2023). High-performance association rule mining: Mortality prediction model for cardiovascular patients with COVID-19 patterns. Alexandria Engineering Journal, 71, 347–354.

Palermo dos Santos, A. C., Japur, C. C., Passos, C. R., Lunardi, T. C. P., Lovato, W. J., & Pena, G. das G. (2022). Nutritional risk, not obesity, is associated with mortality in critically ill COVID-19 patients. Obesity Research and Clinical Practice, 16(5), 379–385.

Sarkar, S., Das, D., Borsingh Wann, S., Kalita, J., & Manna, P. (2021). Is diabetes mellitus a wrongdoer to COVID-19 severity? Diabetes Research and Clinical Practice, 178, 108936.

SatgasCovid-19. (2021). Monitoring Pemantauan Protokol Kesehatan di Wilayah Indonesia. In Satuan Tugas Penanganan COVID-19. Retrieved from

Setyorini, Y., Ardesa, Y. H., & Darmawan, R. E. (2022). Indonesians’ readiness in facing long-term COVID-19 pandemic. Jurnal Ners, 17(1), 14–18.

Shams, M., & Nasreen, M. (2023). International Journal of Disaster Risk Reduction Socio-economic impacts of Covid-19 through gender lens : A situational assessment in Dhaka city , Bangladesh. International Journal of Disaster Risk Reduction, 93(April), 103698.

Sharma, P., Behl, T., Sharma, N., Singh, S., Grewal, A. S., Albarrati, A., … Bungau, S. (2022). COVID-19 and diabetes: Association intensify risk factors for morbidity and mortality. Biomedicine and Pharmacotherapy, 151(April), 113089.

So, M., Takahashi, M., Miyamoto, Y., Ishisaka, Y., Iwagami, M., Tsugawa, Y., … Kuno, T. (2022). The effect of obesity on in-hospital mortality among patients with COVID-19 receiving corticosteroids. Diabetes and Metabolic Syndrome: Clinical Research and Reviews, 16(1), 102373.

Torres, C., García, J., Meslé, F., Barbieri, M., Bonnet, F., Camarda, C. G., … Robine, J. M. (2023). Identifying age- and sex-specific COVID-19 mortality trends over time in six countries. International Journal of Infectious Diseases, 128, 32–40.

Vasudeva, R., Challa, A., Al Rifai, M., Polana, T., Duran, B., Vindhyal, M., & Lewis, E. F. (2022). Prevalence of cardiovascular diseases in COVID-19 related mortality in the United States. Progress in Cardiovascular Diseases, 74, 122–126.

Wang, H., Comfort, H., Aravkin, A. Y., Fuller, J. E., & Allorant, A. (2022). Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020-21. Lancet (London, England), 399(10334), 1513–1536.

WHO. (2020). Coronavirus disease ( COVID-19 ).

WHO. (2022). WHO Coronavirus (COVID-19) Dashboard. Retrieved from WHO website:

Yamamoto, T., Harada, K., Yoshino, H., Nakamura, M., Kobayashi, Y., Yoshikawa, T., … Takayama, M. (2023). Impact of the COVID-19 pandemic on incidence and mortality of emergency cardiovascular diseases in Tokyo. Journal of Cardiology, 82, 134–139.

Zakaria, A., Piper, M., Douda, L., Jackson, N. M., Flynn, J. C., Misra, D. P., … Sankari, A. (2021). Determinants of all-cause in-hospital mortality among patients who presented with COVID-19 to a community teaching hospital in Michigan. Heliyon, 7(12), e08566.